Question follow-through · 13679
Breast Cancer: Genetics
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) define populations with high risk of carrying harmful breast cancer (BRCA) gene variants and (b) increase testing levels amongst those communities.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 26 Jun 2026
- Target answer date
- 30 Jun 2026
- Answer
- 3 Jul 2026 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
26 Jun 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) define populations with high risk of carrying harmful breast cancer (BRCA) gene variants and (b) increase testing levels amongst those communities.
30 Jun 2026
Target answer date
Date supplied by the official written-questions record.
3 Jul 2026
Answer published
Genomic testing in the National Health Service in England is provided through the NHS Genomic Medicine Service and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.